Finanzwire Finanzwire
Basculer en Français
11028 Companies
241689 Keywords
170152 Articles
130124 Press releases
Headlines Articles Press releases Newron Pharmaceuticals S.p.A. Remove
  1. Home
  2. Companies
  3. Newron Pharmaceuticals S.p.A.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 05/02/2023 at 07:00, 3 years 4 months ago

    Newron announces Senior Management Team changes

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 04/18/2023 at 12:15, 3 years 5 months ago

    Newron announces AGM 2023 results  

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 03/28/2023 at 12:30, 3 years 5 months ago

    Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 03/20/2023 at 07:00, 3 years 6 months ago

    Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 03/17/2023 at 07:00, 3 years 6 months ago

    Newron to present at the 31st European Congress of Psychiatry  

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 03/14/2023 at 07:00, 3 years 6 months ago

    Newron announces 2022 financial results and provides outlook for 2023

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 02/16/2023 at 07:00, 3 years 7 months ago

    Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 01/03/2023 at 07:00, 3 years 8 months ago

    Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
Previous page
1 ... 7 8
Accesswire
  • Published on 09/19/2026 at 00:55, 1 day 23 hours ago

    Gossan Resources Announces Changes to Board and Management

  • Published on 09/18/2026 at 23:50, 2 days ago

    Mako Mining Announces Equity Incentive Grants

  • Published on 09/18/2026 at 22:00, 2 days 2 hours ago

    Silver Tiger Announces Results of Annual and Special Meeting

  • Published on 09/18/2026 at 20:35, 2 days 3 hours ago

    Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years

  • Published on 09/18/2026 at 14:30, 2 days 9 hours ago

    AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement

View all ACCESSWIRE
EQS Group
  • Published on 09/20/2026 at 15:10, 8 hours 56 minutes ago

    MSITEK Participates in New York Fashion Week Retail Innovation Lab

  • Published on 09/20/2026 at 09:05, 15 hours 1 minute ago

    Huawei Digital Power Showcases Multi-Scenario Solutions Featuring Grid Forming and AI at IDEE 2026

  • Published on 09/20/2026 at 06:30, 17 hours 36 minutes ago

    Huawei Grid-Interactive AIDC Solution: Shaping the New Paradigm of AI Infrastructure

  • Published on 09/20/2026 at 04:35, 19 hours 31 minutes ago

    How to Achieve Sustainable Power Without Changing Your Existing Backup System

  • Published on 09/19/2026 at 16:40, 1 day 7 hours ago

    2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens

View all EQS
Les Echos
  • Published on 09/18/2026 at 18:34, 2 days 5 hours ago

    Disclosure of transactions in own shares from September 14 to September 18, 2026

  • Published on 09/18/2026 at 17:45, 2 days 6 hours ago

    Press Release_Carrefour Bond_September 2026

  • Published on 09/18/2026 at 17:45, 2 days 6 hours ago

    Share buyback for cancellation

  • Published on 09/17/2026 at 17:40, 3 days 6 hours ago

    Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany

  • Published on 09/16/2026 at 20:46, 4 days 3 hours ago

    LNA SANTE : 2026 First Half Results

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy